12 June 2019 MEDTO19-M-005_ENG v1.0
3 topics of this presentation
① The overview of our product
for COPD patients.
② The medical network
we are building now
③ About our next product that
support patients at home
12 June 2019 MEDTO19-M-005_ENG v1.0
COPD is a global medical problem
COPD( chronic obstructive pulmonary disease) prevalence rate 8.6%
【NICE Study(2001)】
Estimated of patientsTreated patients
Estimated of patients(2014):
Total 5.5 million people
COPD patients (2004):
64 million people
COPD deaths(2005):
>3million people
The 3rd leading cause
of death(2030)
In JAPAN In the world
Medical cost(2014):
146.0 billion yen
Awareness(2018): 28.1%
12 June 2019 MEDTO19-M-005_ENG v1.0
Our Mission
is to raise awareness of health condition and
contribute to extending healthy life.
Awareness and early detectionProviding information to maintain
and not exacerbate the condition
12 June 2019 MEDTO19-M-005_ENG v1.0
4
ATS/ERS
Established
from 1909
The National
Center for Global
Health and
Medicine
IOP-01
Overview of Respiratory Muscle Strength Meter "IOP-01"
The only dedicated measuring device in Japan.
Guidelines of COPD
for Exercise therapy
“Respiratory muscle strength
measurement“ is defined as
a test performed
in the new COPD guidelines.
Recommended
grade A
12 June 2019 MEDTO19-M-005_ENG v1.0
5
IOP-01Class II
medical
device
Features of IOP-01
Launched last November
Pocketable
AnywhereLight
Class Ⅱ medical devicecertified by the Japanese FDA
12 June 2019 MEDTO19-M-005_ENG v1.0
6
Respiratory
CardiovascularIOP-01
COPD・Asthma
Aspiration pneumonia
Tuberculosis
Lung cancer
Rehabilitation/Training for Target Diseases by IOP-01
Cardiac insufficiencyFrail
Sarcopenia
Deglutition disorder
Geriatrics
Otorhinolaryngology
12 June 2019 MEDTO19-M-005_ENG v1.0
7
The medical network we are building now
• Measurement of respiratory muscle strength of healthy
volunteers using ATS / ERS recommended oral pressure
measurement. (Collaborate with University)
• Join a health checkup company. (Coming soon)
• Briefing @ high volume center & University.
• Booth display and seminars @ academic conferences
• Demonstration & Measurement @ Taisho monozukuri festival.
12 June 2019 MEDTO19-M-005_ENG v1.0
8
Business Plan
POST IOP-01
Development of home healthcare equipment (non-medical device)
based on respiratory muscle strength measurement.
@home@clinic
IOP-01
I o T
Network
using our own
patented technology
12 June 2019 MEDTO19-M-005_ENG v1.0
What we offer
① IoT monitoring system of
the respiratory function at home
② Home medication(Medicine / Exercise
/ Nutrition)management system(Collaboration with pharmaceutical manufacturers etc.)
③ Home patient‘s medical information
share system directly with doctors
④ Increase patient’s adherence and motivation
12 June 2019 MEDTO19-M-005_ENG v1.0
Team members
Iwao Kobata (CEO Project Leader)
Director of Medical Device
Development Association.
Working on a number of joint
projects and receiving grants.
Mitsuyoshi Nakaya
Design and development engineer
From Sharp Corporation
Specialized field: Electronic circuit
design
Kenji Nozaki PhD (Engineering)
Sales promotion
From Taiho Pharmaceutical Co., Ltd.
Specialized field: Drug Discovery /
Medical Affaires
Kazuhiro Yoshida
Director
(Leave a Nest Corporation CRO)
Master (Technical Management)
Specialized field: Venture support
Souichi Soroji
Pharmaceutical and marketing
manager
From Roche Diagnostics Ltd.
Yukihiro Ishida
Researcher/Clinical engineer
Taisho Kusunoki Clinic
Deputy General Manager
Medical Presentation Labo
Japan. Representative
Team members
12 June 2019 MEDTO19-M-005_ENG v1.0
CONTACTPresenter : CEO Iwao KobataE-mail :[email protected] : +81-6-6552-0545